Skip to main content

Table 2 BAL inflammatory cells in the three in vivo models of lung inflammation

From: MMP/TIMP expression profiles in distinct lung disease models: implications for possible future therapies

Antigen Model LPS Model Elastase Model
  Neutrophils LMN   Eosinophils LMN   Neutrophils Eosinophils
2 hrs Veh 0.4 ± 0.3 173.8 ± 16.1 1 hr Veh 0.0 0.0 106.3 ± 20.1 2 hrs Veh 21.6 ± 5.9 1.1 ± 0.5
2 hrs OVA 11.7 ± 3.7 115.7 ± 18.8 1 hr LPS 6.1 ± 2.2 102.1 ± 10.7 2 hrs ELA 72.6 ± 15.8 0.0 ± 0.0
4 hrs Veh 2.8 ± 1.6 181.0 ± 16.0 2 hrs Veh 0.5 ± 0.3 155.7 ± 66.9 6 hrs Veh 80.3 ± 30.5 1.2 ± 0.4
4 hrs OVA 144.1 ± 60.1 99.0 ± 8.7 2 hrs LPS 31.9 ± 9.6 71.3 ± 8.9 6 hrs ELA 267 ± 86.7 1.9 ± 0.9
6 hrs Veh 1.5 ± 0.9 175.7 ± 21.3 4 hrs Veh 0.2 ± 0.2 80.7 ± 16.6 24 hrs Veh 46.8 ± 22.4 0.9 ± 0.4
6 hrs OVA 977.1 ± 300.9 150.7 ± 25.9 4 hrs LPS 95.1 ± 24.5 80.0 ± 18.5 24 hrs ELA 382.1 ± 77.4 4.3 ± 2.5
8 hrs Veh 0.2 ± 0.2 173.9 ± 12.3 6 hrs Veh 0.0 ± 0.0 151.8 ± 37.8 48 hrs Veh 8.6 ± 2.3 0.0 ± 0.0
8 hrs OVA 1324.5 ± 293.2 178.1 ± 23.0 6 hrs LPS 110.0 ± 28.3 112.1 ± 10.5 48 hrs ELA 529.4 ± 174.5 4.3 ± 4.3
12 hrs Veh 1.6 ± 0.6 176.4 ± 31.9 8 hrs Veh 0.0 ± 0.0 141.5 ± 31.5 72 hrs Veh 1.1 ± 0.6 0.5 ± 0.2
12 hrs OVA 998.7 ± 312.2 195.2 ± 27.0 8 hrs LPS 80.6 ± 11.2 139.3 ± 11.7 72 hrs ELA 83.2 ± 9.1 0.6 ± 0.6
24 hrs Veh 0.7 ± 0.4 171.2 ± 15.9 12 hrs Veh 0.1 ± 0.1 100.5 ± 13.9 96 hrs Veh 1.9 ± 1.4 0.3 ± 0.3
24 hrs OVA 317.4 ± 141.3 390.1 ± 85.9 12 hrs LPS 41.3 ± 6.5 213.3 ± 10.4 96 hrs ELA 18.1 ± 8.4 1.7 ± 0.9
    24 hrs Veh 0.1 ± 0.1 98.8 ± 15.9 168 hrs Veh 17.2 ± 14.1 0.4 ± 0.4
    24 hrs LPS 7.9 ± 2.0 75.5 ± 12.9 168 hrs ELA 0.6 ± 0.4 0.3 ± 0.3